Alzheimer disease cholinesterase inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Brain Neurofibrillary Tangles Neurofibrils Cerebral Cortex Parasympathetic Nervous System Hippocampus Neurons Substantia Innominata

Organisms2

Rats, Sprague-Dawley Mice, Transgenic

Diseases16

Alzheimer Disease Dementia Dementia, Vascular Lewy Body Disease Plaque, Amyloid Neurotoxicity Syndromes Atrophy Organophosphate Poisoning Bradycardia Memory Disorders Cerebral Amyloid Angiopathy Amnesia Disease Progression Nerve Degeneration Prodromal Symptoms Disease Models, Animal

Chemicals and Drugs83

Cholinesterase Inhibitors Cholinesterases Phenylcarbamates Indans Galantamine Tacrine Butyrylcholinesterase Memantine Physostigmine Acetylcholinesterase Nootropic Agents Neostigmine Methomyl Piperidines Diazinon Pyridostigmine Bromide Edrophonium Trichlorfon Amyloid beta-Peptides Parathion Organothiophosphorus Compounds Chlorpyrifos Sarin Disulfoton Insecticides Soman tau Proteins Echothiophate Iodide Amyloid beta-Protein Precursor Paraoxon Acetylcholine Aldicarb Carbamates Muscarinic Antagonists Chemical Warfare Agents Parasympathomimetics Apolipoprotein E4 Cholinesterase Reactivators Organophosphorus Compounds Thiocholine Pseudocholinesterase Choline Aminacrine Atropine Amyloid Precursor Protein Secretases Dibucaine Dopamine Agents Presenilin-1 Receptors, Muscarinic Muscarinic Agonists Amyloid Tetraisopropylpyrophosphamide Cholinergic Antagonists Dichlorvos Cholinergic Agents Pralidoxime Compounds Succinylcholine Apolipoproteins E Fenitrothion Carbaryl Neuroprotective Agents Peptide Fragments Presenilin-2 Receptors, Cholinergic Alkaloids Butyrylthiocholine Excitatory Amino Acid Antagonists Acetylthiocholine Isoflurophate Receptors, Nicotinic Presenilins Aspartic Acid Endopeptidases Benzoylcholine Aniline Compounds Phosphoramides Nicotinic Antagonists Antipsychotic Agents Pesticides Propoxur Amyloidogenic Proteins Nicotine Biological Markers Protease Nexins

Analytical, Diagnostic and Therapeutic Techniques and Equipment10

Double-Blind Method Severity of Illness Index Magnetic Resonance Imaging Treatment Outcome Longitudinal Studies Autopsy Positron-Emission Tomography Randomized Controlled Trials as Topic Prodromal Symptoms Disease Models, Animal

Psychiatry and Psychology12

Alzheimer Disease Dementia Cognition Disorders Neuropsychological Tests Dementia, Vascular Lewy Body Disease Mental Status Schedule Reality Therapy Cognition Mild Cognitive Impairment Memory Disorders Amnesia

Phenomena and Processes6

Dose-Response Relationship, Drug Aging Time Factors Drug Interactions Synaptic Transmission Brain Chemistry

Anthropology, Education, Sociology and Social Phenomena2

National Institute on Aging (U.S.)Autopsy

Technology, Industry, Agriculture1

Chemical Warfare Agents

Health Care7

Double-Blind Method Severity of Illness Index Treatment Outcome Age of Onset National Institute on Aging (U.S.)Longitudinal Studies Randomized Controlled Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Health Care

Cholinesterase Inhibitors Cholinesterases Alzheimer Disease Phenylcarbamates Indans Galantamine Tacrine Butyrylcholinesterase Memantine Physostigmine Acetylcholinesterase Nootropic Agents Neostigmine Methomyl Piperidines Diazinon Pyridostigmine Bromide Edrophonium Trichlorfon Amyloid beta-Peptides Dementia Parathion Organothiophosphorus Compounds Brain Chlorpyrifos Sarin Disulfoton Insecticides Soman tau Proteins Echothiophate Iodide Amyloid beta-Protein Precursor Cognition Disorders Paraoxon Neurofibrillary Tangles Acetylcholine Neuropsychological Tests Dementia, Vascular Aldicarb Lewy Body Disease Carbamates Plaque, Amyloid Mental Status Schedule Muscarinic Antagonists Chemical Warfare Agents Parasympathomimetics Apolipoprotein E4 Cholinesterase Reactivators Organophosphorus Compounds Reality Therapy Thiocholine Pseudocholinesterase Choline Neurotoxicity Syndromes Aminacrine Atropine Cognition Amyloid Precursor Protein Secretases Dibucaine Dose-Response Relationship, Drug Dopamine Agents Presenilin-1 Receptors, Muscarinic Muscarinic Agonists Amyloid Tetraisopropylpyrophosphamide Atrophy Cholinergic Antagonists Dichlorvos Organophosphate Poisoning Neurofibrils Bradycardia Cerebral Cortex Mild Cognitive Impairment Cholinergic Agents Pralidoxime Compounds Succinylcholine Parasympathetic Nervous System Apolipoproteins E Fenitrothion Carbaryl Neuroprotective Agents Double-Blind Method Peptide Fragments Presenilin-2 Rats, Sprague-Dawley Receptors, Cholinergic Alkaloids Aging Butyrylthiocholine Hippocampus Excitatory Amino Acid Antagonists Neurons Acetylthiocholine Severity of Illness Index Isoflurophate Magnetic Resonance Imaging Receptors, Nicotinic Treatment Outcome Age of Onset

No FAQ available that match "alzheimer disease cholinesterase inhibitors"